Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters.
Although Aweida does not list Sinopsys among its portfolio investments, Sinopsys said in an SEC filing that Jesse Aweida is a board member. Boulder-based High Country Venture and Houston-based MercuryFund list Sinopsys among their portfolio companies.
Help employers find you! Check out all the jobs and post your resume.
